Hla Hla Yee
Psychiatry · Los Angeles, CANPI 1790865822
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $907 and has fallen 50.7% since, to $447 in 2025. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 235 payments — averaging $19.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$761
- Sunovion Pharmaceuticals Inc.$700
- AbbVie$526
- Takeda Pharmaceuticals U.S.A., Inc.$495
- Lundbeck LLC$421
- Johnson & Johnson$322
- plus $1K from 14 others
What the payments were for
- Food & beverage$4,680100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 42 | $761 |
| Sunovion Pharmaceuticals Inc. | 34 | $700 |
| AbbVie(2 entities) | 34 | $526 |
| Takeda Pharmaceuticals U.S.A., Inc. | 30 | $495 |
| Lundbeck LLC | 20 | $421 |
| Johnson & Johnson | 10 | $322 |
| Corium, LLC | 11 | $242 |
| Axsome Therapeutics, Inc. | 7 | $162 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $162 |
| Neurocrine Biosciences, Inc. | 7 | $160 |
| Adlon Therapeutics L.p. | 7 | $147 |
| Vanda Pharmaceuticals Inc. | 5 | $130 |
| Teva Pharmaceuticals USA, Inc. | 6 | $121 |
| E.r. Squibb & Sons, L.L.C. | 4 | $106 |
| Supernus Pharmaceuticals, Inc. | 6 | $98 |
| Ironshore Pharmaceuticals Inc. | 2 | $38 |
| Alkermes, Inc. | 1 | $29 |
| Neuronetics, Inc. | 1 | $22 |
| Indivior Inc. | 1 | $19 |
| Bausch Health US, LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$117
How this compares
$4,680 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nortriptyline Hcl | 16 | $490 |
| Bupropion XlBupropion Hcl | 24 | $296 |
| Modafinil | 16 | $235 |
| Lorazepam | 59 | $197 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $158 |
| Duloxetine Hcl | 35 | $151 |
| Quetiapine Fumarate | 16 | $107 |
| Escitalopram Oxalate | 16 | $106 |
| Aripiprazole | 14 | $79 |
| Sertraline Hcl | 24 | $41 |
| Trazodone Hcl | 12 | $37 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Los Angeles
- Jakub JurosLos Angeles$394K
- Derek OttLos Angeles$329K
- William WirshingLos Angeles$205K
- Gil HoftmanLos Angeles$200K
- Lon SchneiderLos Angeles$156K
- Stephen MarderLos Angeles$103K
- John BrooksLos Angeles$80K
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.